Is RESMED INC (RMD) Halal?
Shariah Screening — 5 Standards
Based on financial data from June 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 2.3% / 30% | 3.3% / 30% | 2.7% / 30% | 0.27% / 5% | ✓ HALAL |
| DJIM | 2.3% / 33% | 3.3% / 33% | 2.7% / 33% | 0.27% / 5% | ✓ HALAL |
| MSCI | 10.4% / 33% | 14.8% / 33% | 12.1% / 33% | 0.27% / 5% | ✓ HALAL |
| S&P | 2.3% / 33% | 3.3% / 33% | 2.7% / 33% | 0.27% / 5% | ✓ HALAL |
| FTSE | 10.4% / 33% | 14.8% / 33% | 12.1% / 50% | 0.27% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 61.5% | |
| Operating Margin | 35.2% | |
| Net Margin | 27.5% | |
| Return on Equity (ROE) | 25.7% | |
| Return on Assets (ROA) | 14.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.8B |
| Free Cash Flow | $1.7B |
| Total Debt | $852M |
| Debt-to-Equity | 13.4 |
| Current Ratio | 3.1 |
| Total Assets | $8.2B |
Price & Trading
| Last Close | $222.50 |
| 50-Day MA | $249.88 |
| 200-Day MA | $259.51 |
| Avg Volume | 1.0M |
| Beta | 0.9 |
|
52-Week Range
$199.92
| |
About RESMED INC (RMD)
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Purification Calculator
As a halal stock with 0.27% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is RESMED INC (RMD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), RESMED INC is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is RESMED INC's debt ratio?
RESMED INC's debt ratio is 2.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.4%.
Does RESMED INC require dividend purification?
Yes, RESMED INC has an impermissible income ratio of 0.27%, which means 0.27% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are RESMED INC's key financial metrics?
RESMED INC has a market capitalization of $32.2B, trailing P/E ratio of 21.8, and revenue of $5.1B. The company maintains a gross margin of 61.5% and a net margin of 27.5%. Return on equity stands at 25.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.